Search

Your search keyword '"Narhi LO"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Narhi LO" Remove constraint Author: "Narhi LO"
118 results on '"Narhi LO"'

Search Results

51. Fractionation and characterization of polyclonal antibodies using three progressively more chaotropic solvents.

52. Effect of three elution buffers on the recovery and structure of monoclonal antibodies.

53. Granulocyte-colony stimulating factor maintains a thermally stable, compact, partially folded structure at pH2.

54. Comparison of solution properties of human and rat ciliary neurotrophic factor.

55. Putative folding pathway of insulin-like growth factor-I.

56. Changes in conformation and stability upon formation of complexes of erythropoietin (EPO) and soluble EPO receptor.

57. The majority of stem cell factor exists as monomer under physiological conditions. Implications for dimerization mediating biological activity.

58. Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution.

59. Induction of alpha-helix in the beta-sheet protein tumor necrosis factor-alpha: thermal- and trifluoroethanol-induced denaturation at neutral pH.

60. Induction of alpha-helix in the beta-sheet protein tumor necrosis factor-alpha: acid-induced denaturation.

61. Purification and characterization of human tissue prokallikrein and kallikrein isoforms expressed in Chinese hamster ovary cells.

62. In vitro methionine oxidation of Escherichia coli-derived human stem cell factor: effects on the molecular structure, biological activity, and dimerization.

63. Refolding and oxidation of recombinant human stem cell factor produced in Escherichia coli.

64. Isolation and characterization of a disulfide-linked human stem cell factor dimer. Biochemical, biophysical, and biological comparison to the noncovalently held dimer.

65. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction.

66. The importance of Arg40 and 45 in the mitogenic activity and structural stability of basic fibroblast growth factor: effects of acidic amino acid substitutions.

67. CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide.

68. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64.

69. Studies on the structure and function of glycosylated and nonglycosylated neu differentiation factors. Similarities and differences of the alpha and beta isoforms.

70. Structure and activity of granulocyte colony-stimulating factor derived from CHO cells containing cDNA coding for alternatively spliced sequences.

71. High level expression of human leukemia inhibitory factor (LIF) from a synthetic gene in Escherichia coli and the physical and biological characterization of the protein.

72. Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development.

73. Formation of heterodimers from three neurotrophins, nerve growth factor, neurotrophin-3, and brain-derived neurotrophic factor.

74. The conformational stability of a non-covalent dimer of a platelet-derived growth factor-B mutant lacking the two cysteines involved in interchain disulfide bonds.

75. Effects of peptide length and composition on binding to an empty class I MHC heterodimer.

76. Properties of variant forms of human stem cell factor recombinantly expressed in Escherichia coli.

77. Acid-induced unfolding of brain-derived neurotrophic factor results in the formation of a monomeric "a state".

78. Refolding of brain-derived neurotrophic factor from guanidine hydrochloride: kinetic trapping in a collapsed form which is incompetent for dimerization.

79. Cysteine 17 of recombinant human granulocyte-colony stimulating factor is partially solvent-exposed.

80. Sites of iodination in recombinant human brain-derived neurotrophic factor and its effect on neurotrophic activity.

81. Recombinant human erythropoietin (rHuEPO): cross-linking with disuccinimidyl esters and identification of the interfacing domains in EPO.

82. Production and characterization of an analog of acidic fibroblast growth factor with enhanced stability and biological activity.

83. Comparison of the biophysical characteristics of human brain-derived neurotrophic factor, neurotrophin-3, and nerve growth factor.

84. Mutation of Arg55/56 to Leu55/Ala56 in insulin-like growth factor-I results in two forms different in disulfide structure and native conformation but similar under reverse-phase conditions.

85. Oxidative refolding of insulin-like growth factor 1 yields two products of similar thermodynamic stability: a bifurcating protein-folding pathway.

86. Role of native disulfide bonds in the structure and activity of insulin-like growth factor 1: genetic models of protein-folding intermediates.

87. Characterization of two fluorescent tryptophans in recombinant human granulocyte-colony stimulating factor: comparison of native sequence protein and tryptophan-deficient mutants.

88. Analysis of the heat-induced denaturation of proteins using temperature gradient gel electrophoresis.

89. Conformation of glutathione adduct and oxidized forms of platelet-derived growth factor.

90. Folding and oxidation of recombinant human granulocyte colony stimulating factor produced in Escherichia coli. Characterization of the disulfide-reduced intermediates and cysteine----serine analogs.

91. Induced resistance of trypsin to sodium dodecylsulfate upon complex formation with trypsin inhibitor.

92. Stability of fungal alpha-amylase in sodium dodecylsulfate.

93. Cloning and characterization of a gene encoding extracellular metalloprotease from Streptomyces lividans.

94. Circular dichroism of reduced and oxidized recombinant human epidermal growth factor.

95. Solution structure and dynamics of epidermal growth factor and transforming growth factor alpha.

96. The effect of carbohydrate on the structure and stability of erythropoietin.

97. Glycosylated and unglycosylated recombinant-derived human stem cell factors are dimeric and have extensive regular secondary structure.

98. Stoichiometric complexation of Streptomyces subtilisin inhibitor and subtilisin.

99. Conformational changes of recombinant human granulocyte-colony stimulating factor induced by pH and guanidine hydrochloride.

100. Solvent modulation in hydrophobic interaction chromatography.

Catalog

Books, media, physical & digital resources